MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Cocrystal Pharma, Inc. Common Stock

COCP

#3808
Cocrystal Pharma, Inc. Common Stock
1.04
-2.80%
Sector:
Base:
Profit Currency:
Daily Range
1.02
1.04
Year Range
0.86
2.67
Daily Change
-2.80%
Monthly Change
0.00%
6 month change
-31.58%
Year Change
-40.23%
Previous Close
1.07
Open
1.02
Bid
Ask
Low
1.02
High
1.04
Volume
7
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. COCP
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
COCP
2025.12.18
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Investing Investing
EA TPC GTE CPRT COCP
2025.11.26
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
Investing Investing
COCP
2025.11.26
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Investing Investing
COCP
2025.10.30
Cocrystal Pharma raises $1.03 million in private placement from directors
Investing Investing
COCP
2025.10.27
Cocrystal Pharma receives $500,000 NIH grant for influenza drug
Investing Investing
COCP
2025.09.15
Cocrystal Pharma closes $4.7 million registered direct offering
Investing Investing
COCP
2025.09.12
Cocrystal Pharma raises $4.7 million in registered direct offering
Investing Investing
COCP
2025.09.12
Cocrystal’s norovirus drug CDI-988 advances to phase 1b study
Investing Investing
COCP
2025.06.20
H.C. Wainwright lowers Cocrystal Pharma stock price target on dilution
Investing Investing
COCP
2025.06.05
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
Investing Investing
COCP
2025.05.29
Cocrystal’s flu drug shows promise against H5N1 strain
Investing Investing
COCP
2025.05.15
Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd